Medications

Biogen pulls controversial Alzheimer's drug Aduhelm

A controversial Alzheimer's drug that was trumpeted as the first to ever treat the cognitive decline associated with the devastating brain disorder has been pulled from the market, its maker Biogen announced Wednesday.

Cardiology

Research reveals new hope for obesity-induced heart disease

Obesity-induced heart disease, which affects up to 10% of the population in certain age ranges, is considered an untreatable condition and 75% of people don't survive more than five years beyond diagnosis.

Alzheimer's disease & dementia

Predicting Alzheimer's dementia in oldest of the old

A new study indicates that severity of amyloid deposition in the brain—not just age—may be key to determining who will benefit from new anti-amyloid therapies to delay the progression of Alzheimer's disease.

page 2 from 37